Sonnet BioTherapeutics Holdings, Inc.
An oncology-focused biotechnology company with a proprietary platform for innovating mono- and bispecific biologics. The company is in clinical development for solid tumor indications, including non-small cell lung cancer and head and neck cancer, as well as researching and developing cytokine-derived product candidates. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | New Jersey |
Employees | 12 |
Founded | |
Financials | |
|---|---|
Market Capitalization | 4.55M |
Revenue | 0.09M |
Operating Income | -12.66M |
Operating Margin | -13655.51% |
Net Income | -8.43M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 3730 / 5373 |
Sector : Healthcare | 398 / 1144 |
Industry : Biotechnology | 131 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 5405 / 5565 |
Sector : Healthcare | 1100 / 1182 |
Industry : Biotechnology | 619 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 3394 / 5436 |
Sector : Healthcare | 316 / 1164 |
Industry : Biotechnology | 98 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 4941 / 5330 |
Sector : Healthcare | 1023 / 1174 |
Industry : Biotechnology | 545 / 667 |